Amebiasis Treatment Market

Amebiasis Treatment Market - Size, Share,
Growth, Outlook, and Opportunity Analysis,
2018-2026
Amebiasis is an infection of the intestine caused by a parasite Entamoeba Histolytica. Symptoms of
this disease include loose stool, abdominal cramping, and stomach pain. Amebiasis is common in
regions with low developed sanitation facilities such as Asia Pacific, Central America, South America,
and some parts of Africa. Amebiasis is mainly transmitted through water or food contaminated with
Entamoeba Histolytica. Amebiasis can lead to diarrhea (with or without blood) in both adults and
children, leading to high morbidity and mortality. The organism, Entamoeba Histolytica, can damage
organ and may require surgical intervention, if the colon and other tissues have undergone
perforation. However, amebiasis can be treated with some antibiotic, anti- parasitic, and antiprotozoal
drugs such as metronidazole, paromomycin, and tinidazole. Diagnosis of this disease is usually made
by microscopic identification of the microorganism in a stool specimen.
Request Sample Copy of Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/1595
Amebiasis Treatment Market Drivers
Increasing approvals and launches of new drugs indicated for the treatment of amebiasis is
expected to be a major factor for growth of amebiasis treatment market. For instance, in 2017,
Dr. Reddy's Laboratories received U.S. Food and Drug Administration (FDA) approval for its
Minolira (minocycline) extended-release tablets, indicated for the treatment of a variety of
bacterial infections and as adjunctive therapy in acute intestinal amebiasis. Moreover, in 2016,
Rising Pharmaceuticals, Inc.—a subsidiary of Aceto Corporation—launched Metronidazole
Tablets, 250mg and 500mg, generic version of Flagyl manufactured by G.D. Searle, LLC’s,
indicated for the treatment of amebiasis and a variety of anaerobic bacterial infections. In 2016,
Mylan Pharmaceuticals Inc. received ANDA approval for its Doryx (Doxycycline Hyclate) DelayedRelease Tablets, 50 mg, indicated for the treatment of acute intestinal amebiasis.
Amebiasis Treatment Market Regional Analysis
Africa is expected to show a significant growth in the global amebiasis treatment market over
the forecast period, owing to high prevalence rate of amebiasis due to poor sanitation and low
availability of clean drinking water. For instance, according to data published by United Nations
Department of Economic and Social Affairs (UNDESA), in 2014, around 115 people in Africa die
every hour from diseases linked to poor sanitation, poor hygiene, and contaminated water. In
Sub-Saharan Africa around 40% of the 783 million people do not have access to a clean source of
drinking water. Furthermore, Asia Pacific region is expected to show significant growth in
amebiasis treatment market over the forecast period, owing to increasing prevalence of
amebiasis in some rural areas of India and China. For instance, according to data published on
National Health Portal of India, in 2015, amebiasis affected about 15% of the total population in
India.
Report includes chapters which deeply display the following deliverable about industry :
• Amebiasis Treatment Market Research Objective and Assumption
• Amebiasis Treatment Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Amebiasis Treatment Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value
Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Amebiasis Treatment Market, By Regions
• Amebiasis Treatment Market Competition by Manufacturers including Production, Share, Revenue,
Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Amebiasis Treatment Market Manufacturers Profiles/Analysis including Company Basic Information,
Manufacturing Base and Its Competitors.
• Amebiasis Treatment Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning
and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Amebiasis Treatment Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Amebiasis Treatment Market Key Players
Key players operating in amebiasis treatment market include Pfizer Inc., Impax
Laboratories, Lupin Pharmaceuticals, Inc., Sanofi, Actelion Pharmaceuticals Ltd.,
Glenmark
Pharmaceuticals,
Sun
Pharmaceutical
Industries
Inc.,
Heritage
Pharmaceuticals Inc., Mission Pharmacal Co., Novel Laboratories, and others.
Inquire Here Before Purchase:
https://www.coherentmarketinsights.com/insight/talk-to-analyst/1595
Amebiasis Treatment Market Taxonomy:
The global amebiasis treatment market is segmented on the basis of drug type, distribution
channel, and region:
By Drug Type•
•
•
•
•
•
•
Metronidazole
Paromomycin
Tinidazole
Iodoquinol
Dehydroemetine
Chloroquine phosphate
Others
By Distribution Channel• Hospitals
• Online Pharmacies
• Retail Pharmacies
By Region
•
•
•
•
•
•
North America
Latin America
Europe
Asia Pacific
Middle East
Africa
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Download Report